We examined the enzyme protein and biosynthesis of human trifunctional protein harboring enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacyl-CoA thiolase activity in cultured skin fibroblasts from two patients with longchain 3-hydroxyacyl-CoA dehydrogenase deficiency. The following results were obtained. (a) In cells from patient 1, immunoblot analysis and pulse-chase experiments indicated that the content of trifunctional protein was < 10% of that in control cells, due to a very rapid degradation of protein newly synthesized in the mitochondria. The diminution of trifunctional protein was associated with a decreased activity of enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacylCoA thiolase, when measured using medium-chain to long-chain substrates. (b) In cells from patient 2, the rate of degradation of newly synthesized trifunctional protein was faster than that in control cells, giving rise to a trifunctional protein amounting to 60% of the control levels. The 3-hydroxyacyl-CoA dehydrogenase activity with medium-chain to longchain substrates was decreased drastically, with minor changes in activities of the two other enzymes. These data suggest a subtle abnormality of trifunctional protein in cells from patient 2. Taken together, the results obtained show that in both patients, long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency is caused by an abnormality in the trifunctional protein, even though there is a heterogeneity in both patients. (J. Clin.
Introduction
Mitochondrial fatty acid 13-oxidation is a major energy-producing pathway. In recent years, an increasing number of hereditary defects of mitochondrial fatty acid 13-oxidation has been reported (1) (2) (3) totic hypoglycemia. Such being the case, these patients may sometimes be misdiagnosed or even considered to be victims of sudden infant death syndrome or Reye syndrome.
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency has been identified as a disorder of mitochondrial fatty acid (3-oxidation. This defect was first suspected in a patient with massive amounts of long-chain 3-hydroxydicarboxylic acids in the urine during a period of acute decompensation. Earlier studies revealed that mitochondria, at least from the rat, contain two distinct 3-hydroxyacyl-CoA dehydrogenases, one located in the mitochondrial matrix with preference for shortchain 3-hydroxyacyl-CoA esters (4, 5) , and the other membrane bound, preferentially reacting with long-chain substrates and therefore called long-chain 3-hydroxyacyl-CoA dehydrogenase (6) . When the 3-hydroxyacyl-CoA dehydrogenase activity of the patients' fibroblasts was assayed, the activity with long-but not short-chain substrates was significantly lower. This disease was therefore named long-chain 3-hydroxyacylCoA dehydrogenase deficiency. About 20 patients with this disorder have been described (7) (8) (9) (10) since the first report in 1989 (11).
Mitochondrial long-chain 3-hydroxyacyl-CoA dehydrogenase from rat liver was recently purified ( 12) . Surprisingly, this activity was found to be part of a multienzyme complex also harboring enoyl-CoA hydratase and 3-ketoacyl-CoA thiolase activity; it was therefore named mitochondrial trifunctional protein (TP) .' This enzyme is a heterooctamer consisting of four moles of the large (a) subunit and four moles ofthe small (f3) subunit. The a subunit of rat mitochondrial trifunctional protein is assumed to possess enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activities, while the ( subunit has 3-ketoacyl-CoA thiolase activity, as deduced from primary structures of the nucleotide sequences of the cloned cDNAs ( 13) . Mitochondrial trifunctional protein also purified from human liver revealed that the human and rat enzymes are similar with respect to molecular and catalytic properties ( 14) .
We report here the molecular and catalytic properties of mitochondrial trifunctional protein in fibroblasts from controls and from two patients with long-chain 3-hydroxyacylCoA dehydrogenase deficiency. We compared the data obtained with human mitochondrial trifunctional protein (human-TP), as purified from human liver, using a procedure similar to that described for the rat enzyme ( 12). The availability of antibodies toward human-TP as well as antibodies against short-chain enoyl-CoA hydratase, short-chain 3-hydroxyacyl-CoA dehydrogenase, and mitochondrial 3-ketoacyl-CoA thiolase facilitated these studies. The long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency is, indeed, due to the functional loss ofthis component ofthe human-TP. These studies also show that, in this disease, there is heterogeneity in the causation of mitochondrial trifunctional protein malfunction.
Methods
Materials. Fatty acids were purchased from Sigma Chemical Co. (St. Louis, MO), and Tokyo Kasei (Tokyo, Japan). DEAE-cellulose was from Seikagaku Kogyo (Tokyo, Japan), phosphocellulose was from Whatman (Maidstone, England), Ultrogel AcA 34 was from IBF biotechnics (Vileneuve-la-Garenne, France), and affinity adsorbent was from Boehringer Mannheim GmbH (Mannheim, Germany). Proteins used as molecular mass markers for SDS-PAGE were obtained from Bio-Rad Laboratories (Richmond, CA).
[35S]Methionine was from Du Pont/NEN Research Products (Boston, MA). Amplify® was from Amersham (Buckinghamshire, England), the fixed Staphylococcus aureus cells were from CalbiochemBehring Corp. (San Diego, CA). All the other reagents were of the purest analytical grade available.
Mitochondrial short-chain acyl-CoA dehydrogenase (15), medium-chain acyl-CoA dehydrogenase ( 15) , long-chain acyl-CoA dehydrogenase ( 15), very long-chain acyl-CoA dehydrogenase ( 16) , mitochondrial short-chain enoyl-CoA hydratase ( 17) , mitochondrial shortchain 3-hydroxyacyl-CoA dehydrogenase (4, 5) , mitochondrial short-chain 3-ketoacyl-CoA thiolase (18) , peroxisomal 3-ketoacylCoA thiolase ( 18) , and peroxisomal bifunctional protein ( 19) were purified from rat liver and the antibodies were raised in rabbits, as described. The antibodies were immunopurified with the use of immunoadsorbent columns that were coupled with the enzymes, as described in the instructions from the manufacturer.
We used skin fibroblasts from two patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. These fibroblasts were grown in Eagle's minimum essential medium containing 10% fetal calf serum (vol/vol) and antibiotics. The cells were used for study 3-4 d after confluence. Findings in the first patient (patient 1 ) have been described elsewhere (20) . This patient presented on the 2nd postnatal day with severe hypotonia and hypoglycemia and died of cardiac failure on the 30th day, despite intensive therapy. The second patient (patient 2) presented early in life with hypoketotic hypoglycemia and a marked 3-hydroxy dicarboxylic aciduria. A defect of mitochondrial f-oxidation at the level of long-chain 3-hydroxyacyl-CoA dehydrogenase was suspected by findings of decreased [1-_14C] palmitic acid oxidation in the skin fibroblasts, and this tentative diagnosis was confirmed by assay of the enzyme activity.
Preparation ofsubstrates. Acetoacetyl-CoA was prepared with CoA and diketene (21) . Crotonyl-CoA was prepared by the method of Steinman and Hill (22) . 2-Hexadecenoyl-CoA, 2-dodecenoyl-CoA, and 2-octenoyl-CoA were prepared by the mixed anhydride method (23). 2-Enoyl-CoAs were converted to 3-ketoacyl-CoAs with use ofthe fatty acid oxidation multienzyme complex ofPseudomonasfragi (24) .
Enzyme assays. The enoyl-CoA hydratase activity was assayed by a decrease in 2-enoyl-CoAs at 280 nm ( 17) . The 3-hydroxyacyl-CoA dehydrogenase activity was measured by 3-ketoacyl-CoA-dependent NADH oxidation (4) . The activity of 3-ketoacyl-CoA thiolase was assayed by the thiolytic reaction and after the absorbance at 303 nm ( 12) .
In the 3-ketoacyl-CoA thiolase assay with the C 12 substrate, the following were used: medium 1, TP was purified from a human liver obtained at autopsy by monitoring the 3-hydroxyacyl-CoA-dependent oxidation of NADH. These procedures were performed at 40C. The frozen liver (25 g) was homogenized in 125 ml of 50 mM K2HPO4, containing 0.1% (vol/vol) hexamethylphosphoric triamide, 2 mM 2-mercaptoethanol, 0.5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1 mM benzamidine. The mixture was centrifuged at 3,000 g for 5 min, and the supernatant was centrifuged at 100,000 g for 60 min. The pellet was homogenized with 40 ml of 10 mM potassium phosphate, pH 7.5, containing 1% sodium cholate, 0.5 M KCl, 0.1% (vol/vol) hexamethylphosphoric triamide, 2 mM 2-mercaptoethanol, and 0.5 mM EDTA. The mixture was kept on ice for 30 min, and subsequently centrifuged at 20,000 g for 15 min. The enzyme was purified by polyethylene glycol no. 6000 precipitation, DEAE-cellulose, and phosphocellulose column chromatography (12) . About 2.5 mg of TP was purified using this procedure.
Purified human-TP (0.25 mg) was dialyzed against 0.15 M NaCl containing 10 mM potassium phosphate pH 7.5, and emulsified with Freund's complete adjuvant. The emulsion was injected into the axillary regions ofa rabbit. Boosters, containing 0.1 mg ofpurified human-TP in emulsion containing Freund's complete adjuvant were injected twice into subcutaneous sites on the dorsum, 4 and 6 wk later. Blood samples were taken from a carotid artery 2 wk after the last booster injection. The antibody was partially purified by fractionation with ammonium sulfate and dialyzed against 0.15 M NaCl containing 10 mM potassium phosphate, pH 7.5.
Extraction ofenoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacyl-CoA thiolase activities in skinJibroblasts. For extraction of enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activities, fibroblasts were sonicated in 25 mM potassium phosphate, pH 7.5, containing 0.2 M sodium chloride, 0.1% (vol/vol) hexamethylphosphoric triamide, 2 mM 2-mercaptoethanol, and 0.5 mM EDTA. We used 0.1 M Tris-Cl, pH 8.3, instead of 25 mM potassium phosphate, pH 7.5, for extraction of 3-ketoacyl-CoA thiolase activity. Tween 20 (20% [ vol/vol]) was added to give a final concentration of0.5% (vol/vol). After incubation on ice for 30 min, the homogenate was centrifuged at 18,000 g for 5 min. The supernatant was used for enzyme assays. Immunoblot analysis using anti-(human-TP) antibody confirmed that the enzyme was completely extracted by the use of either of the two extraction buffers (not shown).
Immunotitration. Fibroblasts' extracts, prepared as described below, were mixed with fivefold the equivalent amounts of the anti-( rat mitochondrial short-chain enoyl-CoA hydratase) antibody, anti-(rat mitochondrial short-chain 3-hydroxyacyl-CoA dehydrogenase) antibody, and anti-(rat mitochondrial 3-ketoacyl-CoA thiolase) antibody, respectively. The mixtures were incubated for 1 h at 4°C, then centrifuged at 18,000 g for 5 min, and the supernatants were used for assay of the enzyme. The amounts ofantibodies required to completely precipitate various enzyme proteins from the fibroblasts' extracts were determined by antibody titration monitoring residual enzyme activities in the supernatant fractions obtained after centrifugation.
Assay and analysis of protein. Protein concentration was determined by a modification (25) of the method of Lowry et al. (26) . SDS-PAGE on a 10% gel was performed according to Laemmli (27) .
Immunoblot analysis was made according to Towbin et al. (28) using an immunoblot system (Amersham Japan) for color development. The bands were quantified using a densitometer (Cliniscan 2®;
Helena, Beaumont, TX).
Pulse-chase experiments. The fibroblasts were grown in 20-cm2 petri-dishes. Pulse labeling was performed as described (29) using 50 ,Ci of ["S]methionine per dish. After a 1-h pulse, the medium was replaced by standard medium and the labeled fibroblasts were chased for 6 and 24 h, respectively. The labeled cells were washed, collected, sonicated in an extraction buffer, and centrifuged. The supernatant was placed in boiling water for 3 min since the anti-(human-TP) antibody precipitated only the denatured human-TP. The labeled protein in the fibroblast extracts was immunoprecipitated with the anti-( human-TP) antibody and fixed Staphylococcus aureus cells. The recovered labeled products were subjected to SDS-PAGE and to fluorography. Competition experiments were done, using an excess amount of human-TP during the immunoprecipitation.
Rhodamine 6G, an inhibitor of transport of the precursors of the mitochondrial enzymes and their processing (30), was added to some preparations of the culture medium to give a final concentration of 2 mg/ml 30 min after start of the preincubation, and to the labeling medium, as described ( 31 ) . The fibroblasts were then labeled and the enzyme was extracted as described above.
Results
Molecular and catalyticproperties ofhuman mitochondrial trifunctionalprotein. Fig. 1 shows the carbon chain length specifities of the three components of human-TP, i.e., enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacylCoA thiolase. All three activities showed a preference for the long-chain substrates, as compared with the short-chain ones. The carbon chain length specificity of human-TP was similar to that of rat mitochondrial trifunctional protein ( 12) .
The molecular mass of native human-TP was estimated to be 507 kD by gel filtration (Ultrogel AcA 34), using the same buffer as that used for rat enzyme ( 12) (not shown). Human-TP consisted of two subunits, and molecular weights were estimated to be 74,000 and 50,000 for the a and 3 subunits, respectively, by SDS-PAGE, and Coomassie blue staining (Fig. 2) . These data indicate that human-TP is a heterooctamer with the a4f34 structure.
Enzyme activities in cultured skin fibroblasts. from controls and from two patients. Activities were measured using both short-and long-chain substrates. In fibroblasts from patient 1, the enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacyl-CoA thiolase activities, as measured with the C16 substrates, were 45, 42, and 0% of the control mean, respectively (thiolase activity with C 16 substrate was assayed with the medium 4). These values are all below the control mean -2 SD. C are all lower than the control mean -1 SD, except for the long-chain 3-hydroxyacyl-CoA dehydrogenase activity, as measured with the C 16 substrate that was below the mean control -2 SD value.
In the presence of 1 mM Mg2+ concentration (medium 3), the assay ofthe thiolase activity with the C 16 substrate showed comparable results between patient 2 and control values. However, the assay of the same activity using medium with 25 mM Mg2+ concentration and 0.1% Triton X-100 (medium 4) revealed a decreased thiolase activity in patient 2. The thiolase activities measured in cells of patient 1 were low, under both experimental conditions. We attribute these results to activation of the thiolase activity of the trifunctional protein and to inhibition of the other 3-ketoacyl-CoA thiolases. In our report on the purification of rat trifunctional protein ( 12), we described the effects of pH and detergent on short-chain 3-hydroxyacyl-CoA dehydrogenase and trifunctional protein. Values for the 3-ketoacyl-CoA thiolase activity of the purified human trifunctional protein toward the C12 substrate with medium 2 and the C 16 substrate with medium 4 were -5-fold and -10-fold higher, respectively, (data not shown). As purified human mitochondrial short-chain 3-ketoacyl-CoA thio- To obtain more information on the significance and interpretation of the data in Table I , the mitochondrial monofunctional enzymes were immunoprecipitated and the residual activities were measured. Fig. 3 shows data from an experiment in which enoyl-CoA hydratase activities were measured using a series of substrates in fibroblasts' extracts, either untreated or treated with an antibody raised against mitochondrial enoylCoA hydratase (crotonase). The results show that immunoprecipitation of mitochondrial enoyl-CoA hydratase led to a virtually complete disappearance ofactivity, as measured with the C4 substrate, both in the control and in fibroblasts from the two patients. The amount of human-TP in cells from patient 1 was little, as described below (see Fig. 6 ), and no significant contribution of peroxisomal bifunctional protein was expected from the remaining enoyl-CoA hydratase activity, based on the very low content of peroxisomal bifunctional protein in fibroblasts estimated by immunoblot analysis. Therefore, we think that the residual enoyl-CoA hydratase activity in fibroblasts from patient 1, especially as measured with C8 and C12 substrates, is due to a distinct enoyl-CoA hydratase with preference for medium-chain substrates. The existence of yet another foxidation enzyme with medium-chain enoyl-CoA hydratase activity has been postulated (32), and we are currently characterizing this protein. Indeed, this substrate specificity differed from that of the purified human mitochondrial short-chain enoyl-CoA hydratase, peroxisomal bifunctional protein, and human-TP. The ratio (C4/C8) ofthe activities with C4 and C8 of mitochondrial short-chain enoyl-CoA hydratase and peroxisomal bifunctional protein was -2 and 0.4, respectively (our unpublished observation). Differences between activities in the controls and in patient 1 after immunoprecipitation (Fig. 3  B) are plotted in Fig. 3 C. The carbon chain length specificity in Fig. 3 C was similar to that of purified human-TP (Fig. 1 A) .
When the fibroblast extracts were treated with the anti-(mitochondrial short-chain 3-hydroxyacyl-CoA dehydrogenase) antibody, the 3-hydroxyacyl-CoA dehydrogenase activity with the C4 substrate was markedly reduced, and the residual 3-hydroxyacyl-CoA dehydrogenase activities with medium-chain to long-chain substrates in the patients' cells were < 20% of those in the control cells (Fig. 4, A and B) . The difference between the activities in control fibroblasts and fibroblasts from patient 1 after immunoprecipitation (Fig. 4 B) are represented in Fig. 4 C. The results show that the carbon chain length specificity, as observed in Fig. 4 C, was similar to that of purified human-TP (Fig. 1 B) .
After treatment of the fibroblasts' extracts with the anti-(mitochondrial 3-ketoacyl-CoA thiolase) antibody, residual 3-ketoacyl-CoA thiolase activities were measured with the C4, C8, C12, and C16 substrates (Fig. 5 B) . In Fig. 5 , A-C, thiolase activities with the C 12 and C 16 substrates were determined using media 2 and 4, respectively. The residual 3-ketoacyl-CoA thiolase activity with the C4 substrate may be due to mitochondrial and/or cytosolic acetoacetyl-CoA thiolase. carbon chain length of substrates was very low, the residual 3-ketoacyl-CoA thiolase activities with the medium-chain substrates may be partly due to peroxisomal 3-ketoacyl-CoA thiolase (Fig. 5 B) . Differences in the activities, as measured in control and patient 1 fibroblasts after immunoprecipitation (Fig. 5 B) , are given in Fig. 5 C. The carbon chain length specificity in Fig. 5 Cwas dissimilar to that of purified human-TP (Fig. 1 C) since different medium was used for the thiolase assay.
Immunoblot analysis. 1 with lanes 2 and 3) . Subsequent studies showed this to be due to differences in ionic composition ofthe samples. In a separate experiment, we confirmed by examination of the mobilities of a mixture of the fibroblast extract and the purified enzyme that the purified human-TP and the human-TP in skin fibroblasts have the same mobility. The signal bands ofboth a and (3 subunits ofhuman-TP in skin fibtoblasts were quantified by densitometry. The ratios of intensities of a and (3 subunits were nearly the same as those of A .S C r. were plotted (C).
the purified enzyme preparation, and the content of human-TP in the two cell lines (Fig. 6, lanes 2 and 3) was estimated to be -0.07% of total protein of the control fibroblasts.
No difference in the mobilities of the a and (3 subunits in the patients' cells could be detected. In cells from patient 1 (Fig. 6, lanes 4 and 5) , the intensity of the signal for the a subunit was < 5% of that in control cells, whereas the signal for the (3 subunit was hardly detectable. In cells from patient 2 (Fig. 6, lanes 6 and 7) , the intensities of both signals were -60% of those of the control, thereby suggesting the presence of virtually normal mitochondrial trifunctional protein in cells from patient 2, in agreement with the data in Table I. In both patients' cells, the contents of seven mitochondrial (short-, medium-, long-, very long-chain acyl-CoA dehydrogenase, short-chain enoyl-CoA hydratase, short-chain 3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacyl-CoA thiolase) and two peroxisomal (bifunctional protein and 3-ketoacyl-CoA thiolase) enzymes were estimated by immunoblot analysis and found to be comparable to the amounts detected in control cells (data not shown).
Pulse-chase experiments. In cells from patient 1 (Fig. 7 Fig. 7 A, lanes 1-4 of patient 2), the radioactivity in the a and the ,B subunits after a 1-h pulse labeling was 70 and 120%, respectively, of that in the control cells. Thus, both subunits in cells from patient 2 were degraded more rapidly than in the control cells, the value being -50% of that in the control cells after a 24-h chase. These findings suggest that the rates of synthesis and degradation of the enzyme in the patients' cells were altered. Fluorographic analysis of mitochondrial shortchain 3-hydroxyacyl-CoA dehydrogenase was made as the positive control, using the same samples (Fig. 7 B) . Fig. 8 shows the results ofpulse labeling experiments in the presence and absence of rhodamine 6G (R6G). In the absence of R6G, the fluorographic bands corresponding to the mature forms of the a and ,B subunits were apparent in cells from control and patients (Fig. 8, lanes 2) . In the presence of R6G, precursors of the a and f3 subunits were clearly observed in the control and patients' cells (Fig. 8, lanes 1 ). These data suggest that both the a and ,B subunits in the two patients' cell lines were synthesized in their correct precursor forms and with the same size as in the controls. Furthermore, the data of Fig. 8 suggest that the precursors were imported normally into the mitochondria and were subsequently processed to be followed by rapid degradation.
Oxidation of [1-_"C]palmitic acid. Oxidation of [1-14C]-palmitic acid to acid soluble products was quantitated as described earlier (33) . [1-'4C]Palmitate oxidations were decreased in fibroblasts from both patients to virtually the same extent, residual activities amounting to 32 and 31%, respectively, (control values: 1.63±0.41 nmol/h per mg protein; n = 6). These results indicate that, in fibroblasts, TP plays an important role in long-chain fatty acid oxidation.
Discussion
Long-chain 3-hydroxyacyl-CoA dehydrogenase does not appear to be a monofunctional enzyme protein but rather part of a complex also harboring enoyl-CoA hydratase and 3-ketoacylCoA thiolase activities. Earlier, we purified this mitochondrial fatty acid oxidation multienzyme complex from rat liver ( 12) and named it "trifunctional protein." Previous biochemical findings indicated that this "trifunctional protein deficiency" can be divided into two groups. In group 1 there was significant diminution in long-chain 3-hydroxyacyl-CoA dehydrogenase activity (1O). The major part of the trifunctional protein deficiency is included in this group, and the content of trifunctional protein in these patients is the same as in controls or is slightly diminished (T. Kamijo, unpublished observation). In group 2, all three enzyme activities were greatly diminished (20, 32) .
In the present work, we analyzed the underlying basis for the enzyme defect in cultured skin fibroblasts from two patients, one suspected of having a combined deficiency of all three enzyme activities, as catalyzed by the mitochondrial (-oxidation multifunctional protein, while the other was found to have an isolated deficiency of long-chain 3-hydroxyacylCoA dehydrogenase activity with near normal values for the two other enzyme activities ( Table I ). The availability of specific antibodies raised against various monofunctional mitochondrial fatty acid f(-oxidation enzyme proteins, as purified from rat liver, facilitated study on the trifunctional protein in fibroblasts from the patients. Results of immunoprecipitation experiments presented in Figs. 3-5 together with immunoblotting data in Fig. 6 clearly show that the trifunctional enzyme is defective in the fibroblasts from both patients, albeit the extent of dysfunction of trifunctional protein in these two cell lines was markedly different (Figs. 3-6 ).
When biosynthesis, import into mitochondria, and degradation of human-TP in cells from patient 1 were studied (Figs. 7 and 8), we found that biosynthesis ofthe two subunits, a and (, occurred at rates of 150 and 19%, respectively, as compared with findings in control cells. Furthermore, the data indicate that the two subunits were normally imported into the mitochondria and processed, followed by a rapid rate of degradation. The rapid disappearance of the (3 subunit, as compared with the a subunit, suggests that the ( subunit in cells from patient 1 is not normal with respect to biosynthesis and stability. Presumably, this leads to a disturbed formation of the enzyme complex resulting in lability of the a subunit as a secondary consequence.
In cells from patient 2, the a and (3 subunits were present at levels of -60%, as compared with control cells, hence, formation of the a4(4-enzyme complex probably occurs normally in these cells. Interestingly, the 3-hydroxyacyl-CoA dehydrogenase activity in these cells was decreased to the same extent as in cells from patient 1, with near normal activity of enoyl-CoA hydratase. Since the a subunit harbors both enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activity, these results suggest that the mutation in patient 2 affects only the 3-hydroxyacyl-CoA dehydrogenase domain of TP. In agreement with the reduced amounts of trifunctional protein, as found by immunoblotting of fibroblasts from patient 2, 3-ketoacyl-CoA thiolase activities were found to be intermediate, as compared with the activities in cells from control and patient 1, respectively. Figs. 7 and 8 show rates ofsynthesis ofthe a and (3 subunits in patient 2 cells of 70 and 120%, respectively, as compared with control cells, followed by normal import into mitochondria and processing. Interestingly, the (3 subunit appeared to be degraded more rapidly in cells from patient 2 (Fig. 8) .
We propose that the group 1-type trifunctional protein deficiency is caused by abnormality of the a subunit, while the group 2-type trifunctional protein deficiency is caused by abnormality of the (3subunit. The hypothesis based on primary structures deduced from nucleotide sequences of the subunits ofthe enzyme is that the a subunit ofTP has enoyl-CoA hydratase plus 3-hydroxyacyl-CoA dehydrogenase activities and the ( subunit of TP harbors 3-ketoacyl-CoA thiolase activity ( 13) .
